Evidence map›Paper›PMID 35166055›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2022

The Prominent Role of Hematopoietic Peptidyl Arginine Deiminase 4 in Arthritis: Collagen- and Granulocyte Colony-Stimulating Factor-Induced Arthritis Model in C57BL/6 Mice.

Shoichi Fukui, Sarah Gutch, Saeko Fukui, Deya Cherpokova, Karen Aymonnier, Casey E Sheehy, Long Chu, Denisa D Wagner

Open access · greenAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Citrullination of matrisomal proteins in health and diseases.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Thromboinflammation: From Atherosclerosis to COVID-19.Arteriosclerosis, thrombosis, and vascular biology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Shoichi FukuiChildren's Hospital and Harvard Medical School, Boston, Massachusetts.ORCID 0000-0001-5487-4692
Sarah GutchBoston Children's Hospital, Boston, Massachusetts.
Saeko FukuiBoston Children's Hospital, Boston, Massachusetts.
Deya CherpokovaChildren's Hospital and Harvard Medical School, Boston, Massachusetts.
Karen AymonnierChildren's Hospital and Harvard Medical School, Boston, Massachusetts.
Casey E SheehyBoston Children's Hospital, Boston, Massachusetts.
Long ChuBoston Children's Hospital, Boston, Massachusetts.
Denisa D WagnerChildren's Hospital and Harvard Medical School, Boston, Massachusetts.
Boston Children's Hospital · US

Funding

How inflammation and thrombosis fuel disease and aging: Focus on NETsR35HL135765 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI WAGNER, DENISA D · 2017 to 2023
$6.2M
NHLBI NIH HHS R35 HL135765
6 · The paper itself

Abstract

objectiveGenome-wide association studies have connected PADI4, encoding peptidylarginine deiminase 4 (PAD4), with rheumatoid arthritis (RA). PAD4 promotes neutrophil extracellular trap (NET) formation. This study was undertaken to investigate the origin of PAD4 and the importance of NET formation in a C57BL/6 mouse model of arthritis.

methodsTo permit the effective use of C57BL/6 mice in the collagen-induced arthritis (CIA) model, we introduced the administration of granulocyte colony-stimulating factor (G-CSF) for 4 consecutive days in conjunction with the booster immunization on day 21. Mice with global Padi4 deficiency (Padi4

resultsG-CSF significantly increased the incidence and severity of CIA. G-CSF-treated mice showed elevated citrullinated histone H3 (Cit-H3) levels in plasma, while vehicle-treated mice did not. Immunofluorescence microscopy revealed deposition of Cit-H3 in synovial tissue in G-CSF-treated mice. Padi4

conclusionWe succeeded in developing an arthritis model suitable for use in C57BL/6 mice that is fully compliant with high animal welfare standards. We observed a >90% incidence of arthritis in male mice and detectable NET markers. This model, with some features consistent with human RA, demonstrates that hematopoietic PAD4 is an important contributor to arthritis development and may prove useful in future RA research.

Indexed as

Arthritis, ExperimentalArthritis, RheumatoidProtein-Arginine Deiminase Type 4AnimalsCollagenGenome-Wide Association StudyGranulocyte Colony-Stimulating FactorMaleMiceMice, Inbred C57BLProtein-Arginine DeiminasesX-Ray MicrotomographyCollagenGranulocyte Colony-Stimulating FactorPadi4 protein, mouseProtein-Arginine DeiminasesProtein-Arginine Deiminase Type 4

Identifiers

PMID35166055
PMCPMC9246839
OpenAlexW4212770768

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.